Beyond GABA, DSIP influences several other neurotransmitter systems
The first glucagon/GLP-1 receptor co-agonist was discovered and validated in preclinical models in 2009
Researchers exploring other pathways, from growth hormone secretagogues like CJC1295 Ipamorelin to neuroregenerative compounds, need that same guarantee of purity
Due to its dual-peptide profile, it is frequently examined in structured investigations focusing on signalling pathway interaction, recovery-response dynamics, and peptide stability within controlled research environments
When used together, BPC-157 and GHK-Cu may have a synergistic effect on wound healing
For a lab working on neurodegeneration, that focus is exactly what you want to see first